You probably own crypto but can’t actually spend it anywhere that matters. SpacePay thinks that’s ridiculous and built something to fix it. This London fintech startup lets businesses accept cryptocurrency payments through their existing card readers. The platform works with over 325 different wallets and charges just 0.5% per transaction. They’ve already pulled in over […]You probably own crypto but can’t actually spend it anywhere that matters. SpacePay thinks that’s ridiculous and built something to fix it. This London fintech startup lets businesses accept cryptocurrency payments through their existing card readers. The platform works with over 325 different wallets and charges just 0.5% per transaction. They’ve already pulled in over […]

This Undervalued Altcoin Could Be the Best Crypto to Invest In Right Now – Meet SpacePay

This Undervalued Altcoin Could Be the Best Crypto to Invest In Right Now - Meet SpacePay

You probably own crypto but can’t actually spend it anywhere that matters. SpacePay thinks that’s ridiculous and built something to fix it.

This London fintech startup lets businesses accept cryptocurrency payments through their existing card readers. The platform works with over 325 different wallets and charges just 0.5% per transaction. They’ve already pulled in over $1.4 million during their presale, so clearly people think they’re onto something real.

Why This Undervalued Altcoin Deserves Serious Attention

SpacePay flies under the radar as an undervalued altcoin because it’s not chasing trends or making empty promises. Token holders get to vote on what gets built next, receive monthly rewards, and see new features before everyone else does.

The team created 34 billion total tokens but only kept 5% for themselves. What’s compelling about SpacePay is how it generates actual revenue from transaction fees rather than relying entirely on token price increases. The platform has moved past the idea stage with working software that processes real payments.

SpacePay One Testnet Goes Live

SpacePay recently launched SpacePay One Testnet, marking a significant milestone in platform development. The V1 payment API is now live on Base Sepolia and Ethereum Sepolia networks for testing. The testnet features a functional payment widget with seamless checkout flow and multi-chain support. 

This public preview gives everyone a look at the engine that’ll handle instant crypto-to-fiat payments without gas fees. Developers and early users can test things out and share feedback before the full launch.

Integration That Makes Business Sense

Most crypto payment solutions ask merchants to rip out their current systems and start over. SpacePay works with the Android card readers that millions of shops already have sitting on their counters. A software update takes minutes to complete, then businesses can immediately start accepting payments from hundreds of crypto wallets.

The instant conversion feature protects merchants from price swings. Someone pays with Bitcoin, but the business receives dollars in their account within seconds. Supporting 325+ wallets was smart planning since customers can use whatever app they prefer without downloading something new.

Low Fees Save Everyone Money

Traditional payment processors charge businesses between 2% and 4% per transaction. SpacePay only takes 0.5%, which means businesses keep more of their revenue. Think about a restaurant doing $25,000 in sales each month – credit card companies would grab anywhere from $500 to $1,000 in fees, but with SpacePay, that cost drops to $125.

Customers benefit from this structure too. Many crypto payment systems charge users extra fees for converting their digital assets. SpacePay eliminates these charges, so people can spend their crypto without watching transaction costs eat into their purchase value.

Visit SpacePay Presale

The Best Crypto to Invest In Right Now Solves Real Problems

There are roughly 400 million crypto owners around the world who can’t spend their digital money on much of anything useful. The best crypto to invest in right now fixes that problem by making cryptocurrency work for regular purchases. Younger people especially want these options since they’re already comfortable paying for everything with their phones.

Payment processors keep jacking up their fees, and small businesses feel it the most. Plus, governments have actually written clear rules around crypto payments now, so merchants don’t have to worry about whether they’re breaking some law nobody understands.

Breaking Down $SPY Token Distribution

The $SPY token powers the entire SpacePay ecosystem. Here’s how the 34 billion tokens get allocated:

  • Public Sale: 20% available during presale phases
  • User Rewards: 17% reserved for loyalty programs and active participants
  • Strategic Partnerships: 18% dedicated to business integrations and ecosystem growth
  • Marketing: 18% allocated for community building and awareness
  • Development: 10% funding ongoing platform improvements
  • Reserve Fund: 12% held for future opportunities and initiatives
  • Founders: 5% distributed to the founding team

Token holders receive multiple benefits beyond potential price appreciation. The voting mechanism gives the community real influence over platform decisions. Revenue sharing creates passive income opportunities tied directly to platform performance, while monthly airdrops reward the most engaged users.

Getting Started With SpacePay

Getting into the $SPY token presale is pretty simple. Head to SpacePay’s official website and connect your crypto wallet like MetaMask or WalletConnect. Tokens are going for $0.003181 right now, and you can pay with ETH, BNB, MATIC, AVAX, USDT, USDC, or regular bank cards.

JOIN THE SPACEPAY ($SPY) PRESALE NOW

Website    |    (X) Twitter    |  Telegram

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.0012761
$0.0012761$0.0012761
+24.72%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26